Carrie Brownstein - Chief Medical Officer at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Carrie Brownstein since 03 Feb 2025

Holdings reported by Carrie Brownstein for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 23,687 $1,132,239 $47.80 01 Feb 2023 Direct Common Stock
Common Stock 105,685 $1,087,456 $10.29 04 Oct 2023 Direct

Transactions reported by Carrie Brownstein for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.